Pharmacokinetic imaging of 11C ethanol with PET in eight patients with hepatocellular carcinomas who were scheduled for treatment with percutaneous ethanol injection

Radiology

Volumn 211, Issue 3, 1999, Pages 681-686

  Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^a   Gutzler, Frank ^c   Irngartinger, Giseia ^a   Kontaxakis, George ^a   Kim, Duk Kyu ^b   Oberdorfer, Franz ^a   Van Kaick, Gerhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Dong A University   (South Korea)

^c NONE

Author keywords

Alcohol; Liver neoplasms, chemotherapeutic infusion; Liver neoplasms, radionuclide studies; Liver neoplasms, therapy

Indexed keywords

ALCOHOL; CARBON 13; RADIOISOTOPE; CARBON; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DILUTION; DRUG DISTRIBUTION; FEMALE; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER CANCER; LIVER CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; INTRALESIONAL DRUG ADMINISTRATION; LIVER; LIVER TUMOR; MIDDLE AGED; SCINTISCANNING;

AGED; CARBON RADIOISOTOPES; CARCINOMA, HEPATOCELLULAR; ETHANOL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0033142024     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.211.3.r99jn12681     Document Type: Article

References (20)

1. Bartolozzi C, Lencioni R. Ethanol injection for the treatment of hepatic tumours. Eur Radiol 1996; 6:682-696.
2. Joseph FB, Baumgarten DA, Bernardino ME. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy -work in progress. Radiology 1993; 186:553-556.
3. Nagel HS, Bernardino ME. Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy. Radiology 1993; 189:265-270.
4. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 1995; 22:434-442.
5. Findlay M, Young H, Cunningham D, et al. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 1996; 14:700-709.
6. Dimitrakopoulou A, Strauss LG, Clorius JH, et al. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 1993; 34:1075-1081.
7. Möhler M, Dimitrakopoulou-Strauss A, Gutzler F, Räth U, Strauss LG, Stremmel W. Prognosis assessment in 5-FU-treated colorectal liver metastases by 18-F-FU position emission tomography (PET). Cancer 1998; 83:245-253.
8. Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, et al. Prediction of therapy response using PET and F-18-fluorouracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 1998; 39:1197-1202.
9. 11C]acetyl chloride as the key intermediate (abstr). Presented at the International Conference on Isotopes, Beijing, China, May 7-12, 1995.
10. Kontaxakis G, Tzanakos GS, Strauss LG, Dimitrakopoulou-Strauss A, Mantaka P, van Kaick G. Characteristics of the local convergence behavior of the iterative ML-EM image reconstruction algorithms (abstr). J Nucl Med 1997; 38:P202.
11. Ostertag H, Kübler WK, Doll J, Lorenz WJ. Measured attenuation correction methods. Eur J Nucl Med 1989; 15:722-726.
12. Hoverath H, Kübler WK, Ostertag H, et al. Scatter correction in the transaxial slices of a whole-body positron emission tomograph. Phys Med Biol 1993; 38:712-728.
13. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32:623-648.
14. Livraghi T, Festi D, Monti F, Salmi A, Vettori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986; 161:309-312.
15. Livraghi T, Sangalli G, Giordano F, et al. 240 hepatocellular carcinomas: ultrasound features, tumor size, cytologic and histologic patterns, serum alpha-fetoprotein and HBs Ag. Tumori 1987; 73:507-512.
16. Cottone M, Turri M, Caltagirone M, et al. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alpha-fetoprotein: a prospective study. Hepatogastroenterology 1988; 35:101-103.
17. Sironi S, Livraghi T, DelMaschio A. Small hepatocellular carcinoma treated with percutaneous ethanol injection: MR imaging findings. Radiology 1991; 180:333-336.
18. Shiina S, Yasuda H, Muto H, et al. Percutaneous ethanol injection in the treatment of liver neoplasms. AJR 1987; 149:949-952.
19. Shiina S, Tagawa K, Unuma T, Terano A. A percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma. AJR 1990; 154:947-951.
20. Dimitrakopoulou-Strauss A, Strauss LG, Gutzler F, Oberdorfer F, Irngartinger G, van Kaick G. Positron emission tomography (PET) with C11 ethanol and F18 deoxyglucose (FDG) in hepatocellular carcinomas (HCC) for therapy management (abstr). Radiology 1997; 205(P): 221.